萨瓦拉制药 SVRA
$4.83 +$0.45 (+10.27%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $4.90 +1.45%
开盘$4.46
昨收$4.38
当日区间$4.41 – $4.90
成交量2.23M
市值$992.37M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$40.97M-30.3% YoY
净利润-$40.23M-32.3% YoY
摊薄每股收益-$0.16-14.3% YoY
自由现金流-$29.97M-14.1% YoY
经营现金流-$29.75M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-105.5%
资产收益率-78.3%
投入资本回报率-88.2%
流动比率10.13
负债/资产比率25.2%
现金及投资$173.03M
总负债$30.11M
净现金（净负债）$142.93M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $40.97M | $38.14M | $122.76M | $33.42M | $30.26M |
| 销售及管理费用 | $18.99M | $15.57M | $42.06M | $12.53M | $9.63M |
| -管理费用 | $18.99M | $15.57M | $42.06M | $12.53M | $9.63M |
| 研发费用 | $21.95M | $23.40M | $81.40M | $20.90M | $20.59M |
| 折旧、摊销与折耗 | $28,000.00 | $24,000.00 | $87,000.00 | -$11,000.00 | $36,000.00 |
| -折旧与摊销 | $28,000.00 | $24,000.00 | $87,000.00 | -$11,000.00 | $36,000.00 |
| 其他税费 | $0.00 | -$853,000.00 | -$784,000.00 | $0.00 | $0.00 |
| 营业利润 | -$40.97M | -$38.14M | -$122.76M | -$33.42M | -$30.26M |
| 非经营性利息净收入（支出） | $829,000.00 | $1.06M | $4.16M | $1.20M | $548,000.00 |
| 非经营性利息收入 | $829,000.00 | $1.06M | $4.16M | $1.20M | $548,000.00 |
| 其他收入（支出） | -$92,000.00 | -$204,000.00 | -$236,000.00 | -$12,000.00 | $146,000.00 |
| 证券出售收益 | -$92,000.00 | -$204,000.00 | $310,000.00 | -$12,000.00 | $146,000.00 |
| 特殊收益（费用） | $0.00 | $0.00 | -$546,000.00 | $0.00 | $0.00 |
| 税前利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 净利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 持续经营利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 归属母公司净利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 归属普通股股东净利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 基本每股收益 | -$0.16 | -$0.15 | -$0.53 | -$0.13 | -$0.14 |
| 摊薄每股收益 | -$0.16 | -$0.15 | -$0.53 | -$0.13 | -$0.14 |
| -减：其他特殊支出 | – | – | $546,000.00 | $0.00 | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $192.14M | $221.65M | $253.44M | $253.44M | $140.92M |
| 流动资产合计 | $178.32M | $209.27M | $241.62M | $241.62M | $128.20M |
| 现金及现金等价物与短期投资 | $173.03M | $202.77M | $235.70M | $235.70M | $124.39M |
| -现金及现金等价物 | $41.80M | $38.79M | $33.18M | $33.18M | $16.28M |
| -短期投资 | $131.23M | $163.98M | $202.52M | $202.52M | $108.11M |
| 应收款 | $1.08M | $1.05M | $1.25M | $1.25M | $1.10M |
| -应收税款 | $1.08M | $1.05M | $1.25M | $1.25M | $1.10M |
| 预付资产 | $2.27M | $3.82M | $3.37M | $3.37M | $2.18M |
| 其他流动资产 | $1.78M | $1.37M | $892,000.00 | $892,000.00 | $532,000.00 |
| 非流动资产合计 | $13.82M | $12.38M | $11.82M | $11.82M | $12.73M |
| 固定资产净值 | $641,000.00 | $130,000.00 | $100,000.00 | $100,000.00 | $85,000.00 |
| 商誉及其他无形资产 | $11.29M | $11.36M | $11.64M | $11.64M | $11.65M |
| -其他无形资产 | $11.29M | $11.36M | $11.64M | $11.64M | $11.65M |
| 其他非流动资产 | $1.89M | $886,000.00 | $84,000.00 | $84,000.00 | $990,000.00 |
| 负债合计 | $48.48M | $45.61M | $50.30M | $50.30M | $46.54M |
| 流动负债合计 | $17.60M | $15.54M | $20.40M | $20.40M | $16.76M |
| 应付款 | $7.00M | $4.50M | $5.76M | $5.76M | $4.14M |
| -应付账款 | $7.00M | $4.50M | $5.76M | $5.76M | $4.14M |
| 一年内应计费用 | $6.20M | $9.46M | $7.72M | $7.72M | $8.66M |
| 短期债务及融资租赁负债 | $298,000.00 | $44,000.00 | $7,000.00 | $7,000.00 | $49,000.00 |
| -一年内到期融资租赁负债 | $298,000.00 | $44,000.00 | $7,000.00 | $7,000.00 | $49,000.00 |
| 其他流动负债 | $385,000.00 | $374,000.00 | $362,000.00 | $362,000.00 | – |
| 非流动负债合计 | $30.88M | $30.07M | $29.91M | $29.91M | $29.78M |
| 长期债务及融资租赁负债 | $30.11M | $30.07M | $29.91M | $29.91M | $29.78M |
| -长期债务 | $30.11M | $30.07M | $29.91M | $29.91M | $29.78M |
| 其他非流动负债 | $770,000.00 | – | – | – | – |
| 股东权益合计 | $143.66M | $176.04M | $203.13M | $203.13M | $94.39M |
| 股东权益 | $143.66M | $176.04M | $203.13M | $203.13M | $94.39M |
| 股本 | $204,000.00 | $204,000.00 | $204,000.00 | $204,000.00 | $173,000.00 |
| -普通股 | $204,000.00 | $204,000.00 | $204,000.00 | $204,000.00 | $173,000.00 |
| 资本公积 | $829.59M | $821.64M | $811.10M | $811.10M | $670.22M |
| 留存收益 | -$685.60M | -$645.37M | -$608.09M | -$608.09M | -$575.85M |
| 不影响留存收益的损益 | -$534,000.00 | -$429,000.00 | -$87,000.00 | -$87,000.00 | -$155,000.00 |
| -固定资产原值 | – | – | $2.43M | $2.43M | – |
| -累计折旧 | – | – | -$2.33M | -$2.33M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$29.75M | -$33.05M | -$101.04M | -$25.06M | -$22.53M |
| 持续经营经营活动现金流净额 | -$29.75M | -$33.05M | -$101.04M | -$25.06M | -$22.53M |
| 持续经营净利润 | -$40.23M | -$37.28M | -$118.84M | -$32.24M | -$29.56M |
| 持续经营损益 | $35,000.00 | -$12,000.00 | $704,000.00 | $158,000.00 | $0.00 |
| 折旧、折耗与摊销 | $99,000.00 | $66,000.00 | $87,000.00 | -$129,000.00 | $75,000.00 |
| 其他非现金项目 | $43,000.00 | $160,000.00 | $453,000.00 | $126,000.00 | $128,000.00 |
| 营运资金变动 | $2.96M | -$6.14M | $5.00M | $2.16M | $3.83M |
| -预付资产变动 | $1.48M | -$639,000.00 | $97,000.00 | -$2.35M | $712,000.00 |
| -应付账款及应计费用变动 | $1.48M | -$4.64M | $4.81M | $3.65M | $3.12M |
| -其他流动资产变动 | $0.00 | -$864,000.00 | $98,000.00 | $866,000.00 | $0.00 |
| 投资活动现金流净额 | $32.60M | $38.78M | -$18.44M | -$93.56M | $21.47M |
| 持续经营投资活动现金流净额 | $32.60M | $38.78M | -$18.44M | -$93.56M | $21.47M |
| 固定资产购置及出售净额 | -$222,000.00 | -$54,000.00 | -$22,000.00 | -$2,000.00 | -$2,000.00 |
| 投资购置及出售净额 | $32.82M | $38.83M | -$18.42M | -$93.56M | $21.47M |
| 筹资活动现金流 | $189,000.00 | -$195,000.00 | $137.81M | $135.56M | -$23,000.00 |
| 持续经营筹资活动现金流净额 | $189,000.00 | -$195,000.00 | $137.81M | $135.56M | -$23,000.00 |
| 债务发行及偿还净额 | $0.00 | $0.00 | $2.37M | $0.00 | $1,000.00 |
| 普通股发行净额 | -$5,000.00 | -$240,000.00 | $135.09M | $135.44M | -$24,000.00 |
| 股票期权行使所得 | $194,000.00 | $45,000.00 | $349,000.00 | $119,000.00 | $0.00 |
| 期末现金余额 | $41.80M | $38.79M | $33.18M | $33.18M | $16.28M |
| 现金净变动 | $3.04M | $5.54M | $18.33M | $16.94M | -$1.09M |
| 期初现金余额 | $38.79M | $33.18M | $15.13M | $16.28M | $17.44M |
| 汇率变动影响 | -$30,000.00 | $74,000.00 | -$277,000.00 | -$36,000.00 | -$74,000.00 |
| 自由现金流 | -$29.97M | -$33.10M | -$101.06M | -$25.06M | -$22.53M |
暂无评论——快来第一个聊聊 SVRA。
登录后参与讨论。